TY  - CHAP
M1  - Book, Section
TI  - Parkinson Disease
A1  - Smith, Thomas R.
A2  - Chisholm-Burns, Marie A.
A2  - Schwinghammer, Terry L.
A2  - Malone, Patrick M.
A2  - Kolesar, Jill M.
A2  - Bookstaver, P. Brandon
A2  - Lee, Kelly C.
Y1  - 2022
N1  - 
T2  - Pharmacotherapy Principles & Practice, 6e
AB  - LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Describe  the  pathophysiology  of  Parkinson  disease  (PD)  related  to  neurotransmitter  involvement  and  targets  for  drug  therapy.Recognize  the  cardinal  motor  symptoms  of  PD  and  determine  a  patient’s  clinical  status  and  disease  progression  based  on  clinical  signs,  symptoms,  and  assessment  tools.When  initiating  therapy  for  PD,  recommend  appropriate  drug  therapy  and  construct  patient-specific  treatment  goals.Recognize  and  recommend  appropriate  treatment  for  nonmotor  symptoms.Formulate  a  plan  to  minimize  patient  off  time  and  maximize  on  time  including  timing,  dosage,  and  frequency  of  medications  as  well  as  the  use  of  adjunctive  medications.Recognize  and  treat  motor  complications  in  PD.Construct  appropriate  patient  counseling  regarding  medications  and  lifestyle  modifications  for  PD.Develop  a  monitoring  plan  to  assess  effectiveness  and  adverse  effects  of  treatment.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/10/05
UR  - ppp.mhmedical.com/content.aspx?aid=1187014495
ER  -